Get our eye opening email newsletter delivered to your inbox daily.
Close
GlobalData Healthcare
GlobalData is the market leader in providing actionable insight into the healthcare industry. With market analysts in 18 countries around the world, along with a team of researchers and consultants, we can provide you with the reliable, in-depth industry information you need.
Google, Amazon, and IBM joined forces with Microsoft, Salesforce, and Oracle to pledge to speed up the progress of health data standards and interoperability.
Harmful algal blooms (HABs) have been reported in every US coastal state and their occurrence is likely on the rise, according to the US National Oceanic and Atmospheric Administration (NOAA).
Cases of tick-borne diseases are on the rise globally, with Lyme disease patients increasing by over three-fold in the US alone in the past couple years.
Takeda’s possible $65 billion takeover of Shire could be the largest deal value in pharma this year and combined Takeda Shire company could be catapulted to the ninth position in terms of 2017 sales.
Many research groups and private companies are attempting to develop a test that can accurately and effectively determine whether or not a person has cancer.
The US Senate passed the country’s first major tax reform in over 30 years last month, and the ramifications on the pharmaceutical industry could be vast.
Wearable devices can be used to detect the early signs of diabetes using an artificial intelligence (AI) network called DeepHeart and developed by Cardiogram, a study has found.
Earlier this week US president Donald Trump described the UK’s National Health Service (NHS) as “going broke and not working.” Although many were quick to criticise him this description may hit too close to home for some in the NHS.
With increasingly intelligent artificial intelligence (AI), even high level surgeons might soon be finding themselves replaced by robots as AI exceeds human abilities.
Despite a rise in awareness of the dangers of sun damage to the skin the number of people diagnosed with melanoma is expected to rise in both men and women between now and 2026.
The number of drugs picking up a designation from regulators — first treatments or speciality drugs — across the European Union, the US, and Japan have risen by 117 percent in 10 years.
Humira has set a record for the highest gross-selling drug in the world and contributed 63 percent to AbbVie’s revenue in 2016 alone and expectations are high the blockbuster drug will continue to perform.
While uncertainty has been a theme for most sectors in the UK over recent months, the medical technology (medtech) industry has suffered more than most.